Inhaled nitric oxide for newborns with breathing failure and high blood pressure in the lungs
Treatments studied
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether inhaled nitric oxide gas can help full-term newborns who have severe breathing problems and high blood pressure in their lungs. It aims to improve oxygen levels and reduce the need for more intensive support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be at least 34 weeks old at birth.
- Your baby needs to have been on a breathing machine for more than 24 hours.
- Your baby has a condition where blood pressure in the lungs is too high, confirmed by tests.
- Treatment must start within the first 7 days after birth.
- Your baby cannot have certain serious health issues like major heart defects or severe bleeding in the brain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether inhaled nitric oxide gas helps newborns with a specific type of congenital diaphragmatic hernia (a hole in the diaphragm that lets organs move into the chest) who have low oxygen and high blood pressure in their lungs.
This study tests whether changing oxygen targets in preterm infants with high blood pressure in the lungs (pulmonary hypertension) helps their heart and lungs work better. It may help doctors find the best oxygen levels for these babies.
This study looks at whether an inhaled nitric oxide generator and delivery system can help newborns with high lung blood pressure (pulmonary hypertension). It may help improve oxygen levels during breathing support, but it requires specific medical eligibility and informed consent.
This trial tests whether breathing in nitric oxide gas can improve oxygen levels in adults with moderate to severe acute respiratory distress syndrome (a serious lung condition often caused by pneumonia or sepsis). If you have this condition and meet the requirements, you may be able to join.
This trial tests a new, smart way to slowly reduce (wean) the inhaled nitric oxide gas that helps babies with a serious lung condition called PPHN. If your baby is already responding well to iNO and needs it for at least 24 hours, this study might help make the weaning process safer and more effective.
This trial tests whether giving nitric oxide gas through a breathing tube can improve oxygen levels in patients with severe obesity who are on a ventilator. It may help those whose lungs are struggling due to acute respiratory failure.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.